Anhui Anke Biotechnology (Group) Co., Ltd. (SHE: 300009)
China
· Delayed Price · Currency is CNY 9.22
-0.13 (-1.39%)
Nov 15, 2024, 3:04 PM CST
Anhui Anke Biotechnology (Group) Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 353.13 | 260.23 | 324.59 | 322.56 | 248.07 | 527.26 | Upgrade
|
| Trading Asset Securities | 916.71 | 1,196 | 842.91 | 805.43 | 646.45 | 177.85 | Upgrade
|
| Cash & Short-Term Investments | 1,270 | 1,456 | 1,167 | 1,128 | 894.52 | 705.11 | Upgrade
|
| Cash Growth | 2.04% | 24.69% | 3.50% | 26.10% | 26.86% | 325.60% | Upgrade
|
| Accounts Receivable | 577.64 | 597.44 | 476.3 | 543.89 | 475.6 | 495.98 | Upgrade
|
| Other Receivables | 14.6 | 9 | 11.25 | 46.96 | 96.36 | 128.79 | Upgrade
|
| Receivables | 592.25 | 606.44 | 487.55 | 590.85 | 571.96 | 624.78 | Upgrade
|
| Inventory | 305.68 | 235.22 | 210.48 | 181.25 | 155.12 | 124.39 | Upgrade
|
| Other Current Assets | 72.95 | 28.03 | 45.02 | 21.53 | 19.75 | 20.04 | Upgrade
|
| Total Current Assets | 2,241 | 2,325 | 1,911 | 1,922 | 1,641 | 1,474 | Upgrade
|
| Property, Plant & Equipment | 1,493 | 1,434 | 1,176 | 881.34 | 766.66 | 717.25 | Upgrade
|
| Long-Term Investments | 462.35 | 404.38 | 347.89 | 188.09 | 163.14 | 162.32 | Upgrade
|
| Goodwill | 67.76 | 66.56 | 57.6 | 57.6 | 380.2 | 380.2 | Upgrade
|
| Other Intangible Assets | 421.76 | 450.36 | 275.64 | 126.22 | 119.34 | 134.08 | Upgrade
|
| Long-Term Deferred Tax Assets | 31.47 | 29.53 | 41.8 | 51.22 | 39.65 | 32.12 | Upgrade
|
| Long-Term Deferred Charges | 245.82 | 223.8 | 413.28 | 386.18 | 367.14 | 286.2 | Upgrade
|
| Other Long-Term Assets | 28.11 | 17.1 | 34.41 | 56.81 | 27.39 | 39.71 | Upgrade
|
| Total Assets | 4,991 | 4,951 | 4,257 | 3,669 | 3,505 | 3,226 | Upgrade
|
| Accounts Payable | 172 | 211.7 | 151.01 | 141.11 | 69.88 | 114.99 | Upgrade
|
| Accrued Expenses | 67.74 | 328.25 | 240.6 | 306.76 | 200.45 | 171.07 | Upgrade
|
| Short-Term Debt | 5 | - | 3 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 14.01 | 14 | Upgrade
|
| Current Portion of Leases | 8.13 | 8.81 | 6.08 | 3.3 | - | - | Upgrade
|
| Current Income Taxes Payable | 94.7 | 43.91 | 46.88 | 93.12 | 71.02 | 44.66 | Upgrade
|
| Current Unearned Revenue | 16.79 | 24.43 | 27.96 | 19.51 | 13.43 | 14.02 | Upgrade
|
| Other Current Liabilities | 335.4 | 229.98 | 200.27 | 62.99 | 103.75 | 55.69 | Upgrade
|
| Total Current Liabilities | 699.75 | 847.08 | 675.8 | 626.79 | 472.54 | 414.44 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 14.03 | Upgrade
|
| Long-Term Leases | 42.63 | 47.82 | 24.06 | 23.74 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 107.61 | 113.52 | 114.16 | 107.18 | 94.68 | 87.49 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 8.58 | 10.01 | 41.14 | 7.81 | 9.07 | 10.23 | Upgrade
|
| Total Liabilities | 858.57 | 1,018 | 855.17 | 765.52 | 576.29 | 526.19 | Upgrade
|
| Common Stock | 1,676 | 1,677 | 1,673 | 1,638 | 1,365 | 1,050 | Upgrade
|
| Additional Paid-In Capital | 546.47 | 519.82 | 405.73 | 186.87 | 442.64 | 750.08 | Upgrade
|
| Retained Earnings | 1,939 | 1,767 | 1,337 | 961.26 | 1,028 | 826.3 | Upgrade
|
| Treasury Stock | -223.91 | -226.22 | -207.41 | - | - | - | Upgrade
|
| Total Common Equity | 3,938 | 3,737 | 3,209 | 2,787 | 2,836 | 2,627 | Upgrade
|
| Minority Interest | 194.72 | 194.93 | 193.09 | 116.97 | 92.85 | 73.34 | Upgrade
|
| Shareholders' Equity | 4,132 | 3,932 | 3,402 | 2,904 | 2,929 | 2,700 | Upgrade
|
| Total Liabilities & Equity | 4,991 | 4,951 | 4,257 | 3,669 | 3,505 | 3,226 | Upgrade
|
| Total Debt | 55.76 | 56.63 | 33.14 | 27.04 | 14.01 | 28.03 | Upgrade
|
| Net Cash (Debt) | 1,214 | 1,399 | 1,134 | 1,101 | 880.5 | 677.08 | Upgrade
|
| Net Cash Growth | 0.65% | 23.35% | 3.03% | 25.04% | 30.04% | 930.96% | Upgrade
|
| Net Cash Per Share | 0.73 | 0.84 | 0.69 | 0.69 | 0.54 | 0.41 | Upgrade
|
| Filing Date Shares Outstanding | 1,726 | 1,611 | 1,589 | 1,638 | 1,638 | 1,638 | Upgrade
|
| Total Common Shares Outstanding | 1,726 | 1,611 | 1,589 | 1,638 | 1,638 | 1,638 | Upgrade
|
| Working Capital | 1,541 | 1,478 | 1,235 | 1,295 | 1,169 | 1,060 | Upgrade
|
| Book Value Per Share | 2.28 | 2.32 | 2.02 | 1.70 | 1.73 | 1.60 | Upgrade
|
| Tangible Book Value | 3,448 | 3,220 | 2,875 | 2,603 | 2,336 | 2,112 | Upgrade
|
| Tangible Book Value Per Share | 2.00 | 2.00 | 1.81 | 1.59 | 1.43 | 1.29 | Upgrade
|
| Buildings | - | 583.06 | 564.87 | 469.79 | 428.33 | 388.26 | Upgrade
|
| Machinery | - | 624.66 | 562.37 | 528.17 | 513.09 | 362.79 | Upgrade
|
| Construction In Progress | - | 672.51 | 445.68 | 228.75 | 136.79 | 230.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.